Canthacur Liq. 0.7%

Texto original en francés.

Producto de salud natural autorizado en Canadá

Titular

Paladin Pharma Inc.

NPN o DIN-HM

80028872

Estado

Licencia no activa

Fecha de licencia

4 de enero de 2012

Fecha de revisión

No indicada

Forma

Liquide

Vía de administración

Topique

Tipo de solicitud

Non traditionnelle

Composición

Composición medicinal no indicada.

Ingredientes no medicinales

Monoéthyl éther d'éthylène glycol, Triton X-45, Ethylcellulose, Acetone, Collodion, Castor Oil

Dosis recomendadas en Canadá

Usos autorizados en Canadá

Canthacur is to be used topically for the removal of benign epithelial growths such as warts (verruca vulgaris) or molluscum contagiosum. Because of the absence of scarring. Canthacur is useful for treating exposed areas where cosmetic results are important. Painless application and the absence of instruments make it especially useful for treating children.

Texto original en inglés.

Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.

Advertencias en Canadá

Cautions and Warnings : Cantharidin is a strong vesicant and Canthacur may produce blisters if it comes into contact with normal skin or mucous membrane. If spilled on skin, wipe off at once, using acetone, alcohol or tape remover. Then wash vigorously with warm soapy water and rinse well. If spilled on mucous membrane or in eyes, flush with water, remove the precipitated film, and flush with water for an additional 15 minutes. Canthacur is a potent vesicant and is to be applied only by the doctor. It is recommended that care be used in the selection of patients to be treated with Canthacur and the method used, the doctor developing his own experience and technique. Care should be used in selection of site of application since residual pigmentation may occur (rarely). It is recommended that patients be advised of effect and possible results of treatment. Do not use on mucosal tissue. Do not use if growth or surrounding tissue is inflamed or irritated. Do not use on diabetics, or people with poor blood circulation, nor on moles, birthmarks, or unusual warts with hair growing from them. Larger areas should not be treated at one time since discomfort may be excessive and systemic absorption may result. The use of Canthacur during pregnancy or in nursing mothers is not recommended since there have been no adequate and well controlled studies in the use of cantharidin in pregnant women or in nursing mothers.

Texto original en inglés.

Contra-Indications : Canthacur is not recommended for the treatment of mosaic warts.

Texto original en inglés.

Known Adverse Reactions : The development of annular warts following Canthacur therapy has been reported in a small percentage of patients. These lesions are superficial and, although they may alarm some patients, present little problem. Treatment consists of patient reassurance and retreatment using either Canthacur or other procedures. There has been one report of chemical lymphangitis following use of Canthacur in combination with salicylic acid plaster.

Texto original en inglés.

Fuente

Ficha oficial de Health Canada, licencia 80028872

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.

Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)

Texto original en francés.

La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.

Se desconoce la fecha de la prueba de esta lista de ingredientes.

¿Ha cambiado el producto? Fotografíe el envase.